Trial intelligence / Profile preview

Exercise and Dietary Counseling for Muscle Loss in Obese Adults on GLP-1 Therapy

NCT07554417Phase 4Not yet recruiting

Sponsor
Rice University
Start
Apr 2026
Primary completion
Jun 2026
Countries
1
01

Overview

Phase 4, randomised, open-label trial (2 arms), sponsored by Rice University. Primary endpoint: Change in Skeletal Muscle Mass at 12 weeks. Planned start Apr 2026; status: not yet recruiting.

Beyond the preview

Go deeper on NCT07554417.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07554417.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call